Orthocell (ASX:OCC): All systems go for a US market roll out of its flagship Remplir nerve repair product
Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in…
Read More
Here’s how tariffs impact the stock market and its investors
Many would be wondering how tariffs impact the stock market and its investors. On ‘Liberation Day‘, the returned President Trump…
Read More
What are the oldest companies on the ASX? Here are 5 of them and the secrets to their success!
In this article, we look at 5 of the oldest companies on the ASX. Now, we are not claiming these…
Read More